MedTrace Logo

Prospective Radiomics Study for Breast Cancer

NCT06095414 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2023-10-23

No results posted yet for this study

Summary

The goal of this prospective study is to develop MRI-based models representing tumor microenvironment in participants with invasive breast cancer.

The main purpose of this study is to analyze the association of diffusion-, T2-, and dynamic contrast-enhanced T1-weighted images of 3T MRI before treatment with the immunohistochemical reactivity of tumor microenvironment including the extracellular matrix and immune cells of core-needle biopsy specimens For this purpose, investigators extract 16145 radiomic features from the intratumoral and peritumoral regions on MRI of participants with invasive breast cancer before treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

MRI

MRI based assessment of tumor microenvironment in breast cancer mass

Sponsors & Collaborators

  • Korea University Ansan Hospital

    lead OTHER

Principal Investigators

  • Bo Kyoung Seo, MD., PhD · Korea University Ansan Hospital

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2022-04-30
Completion
2023-08-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06095414 on ClinicalTrials.gov